 | • レポートコード：MRC23Q36767 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（2-3日） • 産業分類：消費財 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のウシ血清代替品市場について調査・分析し、世界のウシ血清代替品市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（人工血清、成長因子サプリメント、その他）、用途別セグメント分析（科学研究、工業生産）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Thermo Fisher、Merck、Cytiva、Biowest、Corning、VWR、R&D Systems、RMBIO、PAN-Biotech、Atlas Biologicalsなどが含まれています。 世界のウシ血清代替品市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、ウシ血清代替品市場規模を推定する際に考慮しました。本レポートは、ウシ血清代替品の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、ウシ血清代替品に関するビジネス上の意思決定に役立てることを目的としています。 ・ウシ血清代替品市場の概要 - 製品の定義 - ウシ血清代替品のタイプ別セグメント - 世界のウシ血清代替品市場規模：タイプ別分析（人工血清、成長因子サプリメント、その他） - ウシ血清代替品の用途別セグメント - 世界のウシ血清代替品市場規模：用途別分析（科学研究、工業生産） - 世界のウシ血清代替品市場規模予測（2018年-2029年） - ウシ血清代替品の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - ウシ血清代替品市場の競争状況およびトレンド ・ウシ血清代替品の地域別市場規模 - 北米のウシ血清代替品市場規模（2018年-2029年） - アメリカのウシ血清代替品市場規模（2018年-2029年） - ヨーロッパのウシ血清代替品市場規模（2018年-2029年） - アジア太平洋のウシ血清代替品市場規模（2018年-2029年） - 中国のウシ血清代替品市場規模（2018年-2029年） - 日本のウシ血清代替品市場規模（2018年-2029年） - 韓国のウシ血清代替品市場規模（2018年-2029年） - インドのウシ血清代替品市場規模（2018年-2029年） - オーストラリアのウシ血清代替品市場規模（2018年-2029年） - 中南米のウシ血清代替品市場規模（2018年-2029年） - 中東・アフリカのウシ血清代替品市場規模（2018年-2029年） ・タイプ別セグメント：人工血清、成長因子サプリメント、その他 - 世界のウシ血清代替品のタイプ別販売量（2018年-2023年） - 世界のウシ血清代替品のタイプ別売上（2018年-2023年） - 世界のウシ血清代替品のタイプ別価格 ・用途別セグメント：科学研究、工業生産 - 世界のウシ血清代替品の用途別販売量（2018年-2023年） - 世界のウシ血清代替品の用途別売上（2018年-2023年） - 世界のウシ血清代替品の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Thermo Fisher、Merck、Cytiva、Biowest、Corning、VWR、R&D Systems、RMBIO、PAN-Biotech、Atlas Biologicals ・産業チェーンと販売チャネルの分析 - ウシ血清代替品産業チェーン分析 - ウシ血清代替品の主要原材料 - ウシ血清代替品の販売チャネル - ウシ血清代替品のディストリビューター - ウシ血清代替品の主要顧客 ・ウシ血清代替品市場ダイナミクス - ウシ血清代替品の業界動向 - ウシ血清代替品市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Bovine Serum Alternative market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Bovine Serum Alternative is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Bovine Serum Alternative is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Bovine Serum Alternative include Thermo Fisher, Merck, Cytiva, Biowest, Corning, VWR, R&D Systems, RMBIO and PAN-Biotech, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bovine Serum Alternative, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bovine Serum Alternative.
The Bovine Serum Alternative market size, estimations, and forecasts are provided in terms of sales volume (Liter) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Bovine Serum Alternative market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bovine Serum Alternative manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Thermo Fisher
Merck
Cytiva
Biowest
Corning
VWR
R&D Systems
RMBIO
PAN-Biotech
Atlas Biologicals
Segment by Type
Engineered Serum
Growth Factor Supplements
Other
Segment by Application
Scientific Research
Industrial Production
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bovine Serum Alternative manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bovine Serum Alternative in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Bovine Serum Alternative Market Overview
1.1 Product Overview and Scope of Bovine Serum Alternative
1.2 Bovine Serum Alternative Segment by Type
1.2.1 Global Bovine Serum Alternative Market Value Comparison by Type (2023-2029)
1.2.2 Engineered Serum
1.2.3 Growth Factor Supplements
1.2.4 Other
1.3 Bovine Serum Alternative Segment by Application
1.3.1 Global Bovine Serum Alternative Market Value by Application: (2023-2029)
1.3.2 Scientific Research
1.3.3 Industrial Production
1.4 Global Bovine Serum Alternative Market Size Estimates and Forecasts
1.4.1 Global Bovine Serum Alternative Revenue 2018-2029
1.4.2 Global Bovine Serum Alternative Sales 2018-2029
1.4.3 Global Bovine Serum Alternative Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Bovine Serum Alternative Market Competition by Manufacturers
2.1 Global Bovine Serum Alternative Sales Market Share by Manufacturers (2018-2023)
2.2 Global Bovine Serum Alternative Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Bovine Serum Alternative Average Price by Manufacturers (2018-2023)
2.4 Global Bovine Serum Alternative Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Bovine Serum Alternative, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bovine Serum Alternative, Product Type & Application
2.7 Bovine Serum Alternative Market Competitive Situation and Trends
2.7.1 Bovine Serum Alternative Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bovine Serum Alternative Players Market Share by Revenue
2.7.3 Global Bovine Serum Alternative Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bovine Serum Alternative Retrospective Market Scenario by Region
3.1 Global Bovine Serum Alternative Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Bovine Serum Alternative Global Bovine Serum Alternative Sales by Region: 2018-2029
3.2.1 Global Bovine Serum Alternative Sales by Region: 2018-2023
3.2.2 Global Bovine Serum Alternative Sales by Region: 2024-2029
3.3 Global Bovine Serum Alternative Global Bovine Serum Alternative Revenue by Region: 2018-2029
3.3.1 Global Bovine Serum Alternative Revenue by Region: 2018-2023
3.3.2 Global Bovine Serum Alternative Revenue by Region: 2024-2029
3.4 North America Bovine Serum Alternative Market Facts & Figures by Country
3.4.1 North America Bovine Serum Alternative Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Bovine Serum Alternative Sales by Country (2018-2029)
3.4.3 North America Bovine Serum Alternative Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bovine Serum Alternative Market Facts & Figures by Country
3.5.1 Europe Bovine Serum Alternative Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Bovine Serum Alternative Sales by Country (2018-2029)
3.5.3 Europe Bovine Serum Alternative Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bovine Serum Alternative Market Facts & Figures by Country
3.6.1 Asia Pacific Bovine Serum Alternative Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Bovine Serum Alternative Sales by Country (2018-2029)
3.6.3 Asia Pacific Bovine Serum Alternative Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Bovine Serum Alternative Market Facts & Figures by Country
3.7.1 Latin America Bovine Serum Alternative Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Bovine Serum Alternative Sales by Country (2018-2029)
3.7.3 Latin America Bovine Serum Alternative Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bovine Serum Alternative Market Facts & Figures by Country
3.8.1 Middle East and Africa Bovine Serum Alternative Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Bovine Serum Alternative Sales by Country (2018-2029)
3.8.3 Middle East and Africa Bovine Serum Alternative Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bovine Serum Alternative Sales by Type (2018-2029)
4.1.1 Global Bovine Serum Alternative Sales by Type (2018-2023)
4.1.2 Global Bovine Serum Alternative Sales by Type (2024-2029)
4.1.3 Global Bovine Serum Alternative Sales Market Share by Type (2018-2029)
4.2 Global Bovine Serum Alternative Revenue by Type (2018-2029)
4.2.1 Global Bovine Serum Alternative Revenue by Type (2018-2023)
4.2.2 Global Bovine Serum Alternative Revenue by Type (2024-2029)
4.2.3 Global Bovine Serum Alternative Revenue Market Share by Type (2018-2029)
4.3 Global Bovine Serum Alternative Price by Type (2018-2029)
5 Segment by Application
5.1 Global Bovine Serum Alternative Sales by Application (2018-2029)
5.1.1 Global Bovine Serum Alternative Sales by Application (2018-2023)
5.1.2 Global Bovine Serum Alternative Sales by Application (2024-2029)
5.1.3 Global Bovine Serum Alternative Sales Market Share by Application (2018-2029)
5.2 Global Bovine Serum Alternative Revenue by Application (2018-2029)
5.2.1 Global Bovine Serum Alternative Revenue by Application (2018-2023)
5.2.2 Global Bovine Serum Alternative Revenue by Application (2024-2029)
5.2.3 Global Bovine Serum Alternative Revenue Market Share by Application (2018-2029)
5.3 Global Bovine Serum Alternative Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Thermo Fisher
6.1.1 Thermo Fisher Corporation Information
6.1.2 Thermo Fisher Description and Business Overview
6.1.3 Thermo Fisher Bovine Serum Alternative Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Thermo Fisher Bovine Serum Alternative Product Portfolio
6.1.5 Thermo Fisher Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Bovine Serum Alternative Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Merck Bovine Serum Alternative Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Cytiva
6.3.1 Cytiva Corporation Information
6.3.2 Cytiva Description and Business Overview
6.3.3 Cytiva Bovine Serum Alternative Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Cytiva Bovine Serum Alternative Product Portfolio
6.3.5 Cytiva Recent Developments/Updates
6.4 Biowest
6.4.1 Biowest Corporation Information
6.4.2 Biowest Description and Business Overview
6.4.3 Biowest Bovine Serum Alternative Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Biowest Bovine Serum Alternative Product Portfolio
6.4.5 Biowest Recent Developments/Updates
6.5 Corning
6.5.1 Corning Corporation Information
6.5.2 Corning Description and Business Overview
6.5.3 Corning Bovine Serum Alternative Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Corning Bovine Serum Alternative Product Portfolio
6.5.5 Corning Recent Developments/Updates
6.6 VWR
6.6.1 VWR Corporation Information
6.6.2 VWR Description and Business Overview
6.6.3 VWR Bovine Serum Alternative Sales, Revenue and Gross Margin (2018-2023)
6.6.4 VWR Bovine Serum Alternative Product Portfolio
6.6.5 VWR Recent Developments/Updates
6.7 R&D Systems
6.6.1 R&D Systems Corporation Information
6.6.2 R&D Systems Description and Business Overview
6.6.3 R&D Systems Bovine Serum Alternative Sales, Revenue and Gross Margin (2018-2023)
6.4.4 R&D Systems Bovine Serum Alternative Product Portfolio
6.7.5 R&D Systems Recent Developments/Updates
6.8 RMBIO
6.8.1 RMBIO Corporation Information
6.8.2 RMBIO Description and Business Overview
6.8.3 RMBIO Bovine Serum Alternative Sales, Revenue and Gross Margin (2018-2023)
6.8.4 RMBIO Bovine Serum Alternative Product Portfolio
6.8.5 RMBIO Recent Developments/Updates
6.9 PAN-Biotech
6.9.1 PAN-Biotech Corporation Information
6.9.2 PAN-Biotech Description and Business Overview
6.9.3 PAN-Biotech Bovine Serum Alternative Sales, Revenue and Gross Margin (2018-2023)
6.9.4 PAN-Biotech Bovine Serum Alternative Product Portfolio
6.9.5 PAN-Biotech Recent Developments/Updates
6.10 Atlas Biologicals
6.10.1 Atlas Biologicals Corporation Information
6.10.2 Atlas Biologicals Description and Business Overview
6.10.3 Atlas Biologicals Bovine Serum Alternative Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Atlas Biologicals Bovine Serum Alternative Product Portfolio
6.10.5 Atlas Biologicals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bovine Serum Alternative Industry Chain Analysis
7.2 Bovine Serum Alternative Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bovine Serum Alternative Production Mode & Process
7.4 Bovine Serum Alternative Sales and Marketing
7.4.1 Bovine Serum Alternative Sales Channels
7.4.2 Bovine Serum Alternative Distributors
7.5 Bovine Serum Alternative Customers
8 Bovine Serum Alternative Market Dynamics
8.1 Bovine Serum Alternative Industry Trends
8.2 Bovine Serum Alternative Market Drivers
8.3 Bovine Serum Alternative Market Challenges
8.4 Bovine Serum Alternative Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer